Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $42392.0.

  • China Pharma Holdings' Exchange Rate Effect rose 31386.31% to $42392.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$66842.0, marking a year-over-year decrease of 23798.07%. This contributed to the annual value of -$66232.0 for FY2024, which is 30746.12% down from last year.
  • Per China Pharma Holdings' latest filing, its Exchange Rate Effect stood at $42392.0 for Q3 2025, which was up 31386.31% from -$39627.0 recorded in Q2 2025.
  • China Pharma Holdings' 5-year Exchange Rate Effect high stood at $50439.0 for Q4 2023, and its period low was -$153626.0 during Q3 2022.
  • For the 5-year period, China Pharma Holdings' Exchange Rate Effect averaged around -$15417.1, with its median value being -$4092.0 (2021).
  • Within the past 5 years, the most significant YoY rise in China Pharma Holdings' Exchange Rate Effect was 128371.65% (2022), while the steepest drop was 365430.11% (2022).
  • China Pharma Holdings' Exchange Rate Effect (Quarter) stood at -$14578.0 in 2021, then skyrocketed by 126.57% to $3874.0 in 2022, then soared by 1201.99% to $50439.0 in 2023, then crashed by 227.35% to -$64236.0 in 2024, then skyrocketed by 165.99% to $42392.0 in 2025.
  • Its last three reported values are $42392.0 in Q3 2025, -$39627.0 for Q2 2025, and -$5371.0 during Q1 2025.